Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Exploratory Study Evaluating the Efficacy and Safety of Ingenol Mebutate 0.05% Gel for the Treatment of Verruca Vulgaris.

NCT02748902 is registered in ClinicalTrials.gov with Neal D. Bhatia, MD as lead sponsor.

NCT NCT02748902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02748902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Exploratory Study Evaluating the Efficacy and Safety of Ingenol Mebutate 0.05% Gel for the Treatment of Verruca Vulgaris.
Lead sponsor
Neal D. Bhatia, MD
Phase
Phase 1
Overall status
Completed
Start date
April 27, 2016
Completion date
March 30, 2017
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

common warts, verruca vulgaris